University of Pennsylvania

ScholarlyCommons
Departmental Papers (Dental)

Penn Dental Medicine

7-2011

Cytolethal Distending Toxin Damages the Oral Epithelium of
Gingival Explants
M. Damek-Poprawa
University of Pennsylvania

M. Haris
University of Pennsylvania

A. Volgina
University of Pennsylvania

J. Korostoff
University of Pennsylvania

J. M. DiRienzo
University of Pennsylvania

Follow this and additional works at: https://repository.upenn.edu/dental_papers
Part of the Dentistry Commons

Recommended Citation
Damek-Poprawa, M., Haris, M., Volgina, A., Korostoff, J., & DiRienzo, J. M. (2011). Cytolethal Distending
Toxin Damages the Oral Epithelium of Gingival Explants. Journal of Dental Research, 90 (7), 874-879.
http://dx.doi.org/10.1177/0022034511403743

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/dental_papers/181
For more information, please contact repository@pobox.upenn.edu.

Cytolethal Distending Toxin Damages the Oral Epithelium of Gingival Explants
Abstract
The cytolethal distending toxin (Cdt), expressed by the periodontal pathogen Aggregatibacter
actinomycetemcomitans, inhibits the proliferation of cultured epithelial cells by arresting the cell cycle.
The gingival epithelium is an early line of defense against microbial assault. When damaged, bacteria
collectively gain entry into underlying connective tissue where microbial products can affect infiltrating
inflammatory cells, leading to the destruction of the attachment apparatus. Histological evaluation of rat
and healthy human gingival tissue exposed ex vivo to the Cdt for 36 and 18 hours, respectively, revealed
extensive detachment of the keratinized outer layer and distention of spinous and basal cells in the oral
epithelium. Treated human tissue also exhibited disruption of rete pegs and dissolution of cell junctions.
Cells in the connective tissue appeared unaffected. Primary gingival epithelial cells, but not gingival
fibroblasts, isolated from the same healthy human tissue were cell-cycle-arrested when treated with the
toxin. These findings provide new evidence that the Cdt severely damages the oral epithelium, ex vivo, by
specifically targeting epithelial cells, in situ. The Cdt shows preferential targeting of the epithelium as
opposed to connective tissue in animal and human gingival explant models.

Abbreviations: cytolethal distending toxin (Cdt), connective tissue (CT), 4′,6-diamidino-2-phenylindole
(DAPI), human gingival epithelial cells (HGEC), human gingival explants (HGX), human gingival fibroblasts
(HGF), junctional epithelium (JE), oral epithelium (OE), rete pegs (RP), sulcular epithelium (SE)

Keywords
Aggregatibacter actinomycetemcomitans, cytolethal distending toxin, gingival epithelial cells, gingival
fibroblasts, gingival explants

Disciplines
Dentistry

This journal article is available at ScholarlyCommons: https://repository.upenn.edu/dental_papers/181

RESEARCH REPORTS
Biological

M. Damek-Poprawa1, M. Haris2,
A. Volgina1, J. Korostoff2,
and J.M. DiRienzo1*
1

Departments of Microbiology; and 2Periodontics, School of
Dental Medicine, University of Pennsylvania, 240 South 40th
Street, Philadelphia, PA 19104, USA; *corresponding author,
dirienzo@pobox.upenn.edu

Cytolethal Distending Toxin
Damages the Oral Epithelium
of Gingival Explants

J Dent Res 90(7):874-879, 2011

Abstract

Introduction

The cytolethal distending toxin (Cdt), expressed by
the periodontal pathogen Aggregatibacter actino
mycetemcomitans, inhibits the proliferation of cultured epithelial cells by arresting the cell cycle. The
gingival epithelium is an early line of defense against
microbial assault. When damaged, bacteria collectively gain entry into underlying connective tissue
where microbial products can affect infiltrating
inflammatory cells, leading to the destruction of the
attachment apparatus. Histological evaluation of rat
and healthy human gingival tissue exposed ex vivo to
the Cdt for 36 and 18 hours, respectively, revealed
extensive detachment of the keratinized outer layer
and distention of spinous and basal cells in the oral
epithelium. Treated human tissue also exhibited disruption of rete pegs and dissolution of cell junctions.
Cells in the connective tissue appeared unaffected.
Primary gingival epithelial cells, but not gingival
fibroblasts, isolated from the same healthy human
tissue were cell-cycle-arrested when treated with the
toxin. These findings provide new evidence that the
Cdt severely damages the oral epithelium, ex vivo, by
specifically targeting epithelial cells, in situ. The Cdt
shows preferential targeting of the epithelium as
opposed to connective tissue in animal and human
gingival explant models. .
Abbreviations: cytolethal distending toxin (Cdt),
connective tissue (CT), 4′,6-diamidino-2-phenylindole
(DAPI), human gingival epithelial cells (HGEC), human
gingival explants (HGX), human gingival fibroblasts
(HGF), junctional epithelium (JE), oral epithelium (OE),
rete pegs (RP), sulcular epithelium (SE)

T

he end-point of periodontal diseases is the destruction of the tissues that
support and anchor the teeth. This process is initiated by a persistent polymicrobial infection (Armitage, 2010) and sustained by interactions between
the microbial antagonists and host immune system (Taubman et al., 2005).
The gingival epithelium is an early line of defense against these micro-organisms
and functions as part of a signaling network that alerts inflammatory cells
to microbial assault (Handfield et al., 2005). Damage to the epithelial barrier allows pathogens, opportunistic bacterial species, and/or their products to
more easily reach and interact with the underlying connective tissue (CT) and
infiltrating inflammatory cells.
Gingival epithelium consists of oral (OE), sulcular (SE), and junctional
epithelium (JE) (Bosshardt and Lang, 2005). The basal cell layers of all 3
types of gingival epithelia are composed of rapidly proliferating cells that
migrate toward the outer surface of the tissue. The gingival epithelial surface
is under constant assault by biofilm-forming bacteria, including the Gramnegative bacterium, Aggregatibacter actinomycetemcomitans. The cytolethal
distending toxin (Cdt) produced by this bacterium potentially enhances its
ability to interact with, damage, and modulate gene expression of epithelial
cells (Henderson et al., 2010). The Cdt is a secreted heterotrimer that damages
the DNA of susceptible cells, leading to cell-cycle-mediated growth arrest or, in
some cases, apoptosis (Sugai et al., 1998; Mayer et al., 1999). The rapid growth
arrest of Cdt-treated immortalized oral epithelial cell lines, co-cultured with
periodontal ligament fibroblasts (Kang et al., 2005; Kanno et al., 2005),
prompted us to advance the hypothesis that this putative virulence factor
affects the integrity of human gingival epithelial cells (HGEC) in situ.
In this report, we assessed the ability of the Cdt to alter the histology of
gingival tissue from rats and healthy human subjects. Our positive findings
support the development of ex vivo models for assessing the molecular effects
of the Cdt on HGEC in situ. Establishing that the Cdt of A. actinomycetem
comitans affects the integrity of the gingival epithelium justifies targeting this
toxin in therapeutic modalities designed to reduce the severity of some forms
of periodontal disease.

KEY WORDS: Aggregatibacter actinomycetem
comitans, cytolethal distending toxin, gingival epithelial cells, gingival fibroblasts, gingival explants.
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The upper jaws of 6 one-month-old Sprague-Dawley rats were dissected
immediately following death by decapitation of isoflurane-sedated animals.
All procedures were carried out in accordance with the guidelines of the
University of Pennsylvania Institutional Animal Care and Use Committee.
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Human gingival explants (HGX) were obtained during routine crown-lengthening surgeries conducted on 18 physically
healthy adults in the University of Pennsylvania School of
Dental Medicine Graduate Periodontics Clinic. Upon presentation for surgery, all individuals were required to have clinically
healthy periodontal tissues with no plaque or calculus present on
their teeth. The marginal gingiva and/or keratinized gingiva
distal to terminal maxillary teeth was used as the source of tissue
for all toxin experiments. Thus, explants were composed of OE
and underlying CT. For comparison with untreated healthy tissue, HGX were collected during osseous surgeries conducted on
two adults diagnosed with periodontal disease. Microbiological
sampling of these patients was not done prior to surgery. The
protocol for tissue procurement received Institutional Review
Board approval, and all donors provided informed consent.
HGEC and fibroblasts (HGF) were isolated from clinically
healthy human tissue as described previously (Oda and Watson,
1990; Kanno et al., 2005) and were grown in serum-free keratinocyte medium and Medium 199 supplemented with Earle’s
salts and 10% fetal bovine serum (FBS), respectively.

Protein Isolation and Toxin Reconstitution
Recombinant Cdt proteins were isolated by affinity chromatography as described previously (Cao et al., 2005). Heterotrimers
were reconstituted, in a refolding buffer, from wild-type subunits (Mao and DiRienzo, 2002) or CdtBH160A (DiRienzo et al.,
2009).

Histology and Immunostaining
Freshly excised rat jaws were partitioned, and molars with adjacent tissue were exposed to various concentrations of wild-type
(CdtABC) or mutated (CdtABH160AC) toxin for 0 to 48 hrs in
DMEM containing 5% FBS and 1% Antibiotic-Antimycotic
solution (Invitrogen, Carlsbad, CA, USA) at 37°C with 5% CO2.
Samples were fixed in 4% buffered formalin and decalcified in
an acidic Decal Stat High Speed Bone Decalcifier (Decal
Chemical Corporation, Tallman, NY, USA) following the manufacturer’s instructions.
Following excision, HGX were placed in F12 medium, supplemented with 5% FBS and 1% Antibiotic-Antimycotic solution. The tissue was cut into 5-mm pieces and treated, in various
experiments, with 0-10 μg/mL CdtABC or CdtABH160AC. The
toxin-treated samples were incubated at 37°C, with 5% CO2, for
various periods of time ranging from 0 to 36 hrs, then fixed in
4% buffered formalin.
Following incubation, rat and human explants were processed for paraffin sections by the Tissue Processing Service at
the School of Dental Medicine. Sections were stained with
hematoxylin and eosin or labeled with pan-keratin Ab3 mouse
monoclonal antibody (Lab Vision Products, Fremont, CA,
USA), followed by anti-mouse biotinylated antibody and HRPconjugated streptavidin for enzymatic detection with 3,3′ diamino
benzidine (DAB) (R&D Systems, Minneapolis, MN, USA) or
goat anti-mouse Alexa Fluor 488 (Invitrogen) for fluorescent
microscopy. Other sections were labeled with rabbit anti-CdtB
IgG (Cao et al., 2008) and goat anti-rabbit IgG Alexa Fluor 594
(Invitrogen).

Figure 1. Effects of Cdt on the histology of gingival tissue from the upper
jaws of rats. Specimens were incubated with (A) 0, (B) 5, and (C) 10 μg/
mL of CdtABC or (D) 10 μg/mL of CdtABH160AC in tissue culture medium
at 37°C in an atmosphere containing 5% CO2 for 36 hrs. After
incubation, the tissue was decalcified, and representative sections were
stained with hematoxylin and eosin for histological evaluation. Enlarged
areas, designated by the red outline, are shown in the next panel or inset.
JE, junctional epithelium; SE, sulcular epithelium; OE, oral epithelium; RP,
rete pegs; CT, connective tissue. Magnification bars = 100 μm. All
treatments were performed on pieces of tissue cut from the same rat jaw.
Experiments were repeated on tissue from 6 rats. Stained sections from a
representative experiment on a single rat are shown.

Isolated primary cells were grown in 8-well chamber slides
and incubated with either mouse anti-human epithelial cell
adhesion molecule (Ep-Cam EBA-1) antibody (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) or anti-fibroblast CD90/
Thy-1 antigen (Ab-1) antibody (Oncogene Research Products,
La Jolla, CA, USA), followed by Alexa Fluor 488 goat antimouse IgG.
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Figure 2. Effects of Cdt on the integrity of human gingival tissue. (A) Stability of untreated (no toxin) HGX maintained ex vivo. Explants from
systemically and periodontally healthy patients were incubated for 0 hr, 18 hrs, and 24 hrs in tissue culture medium at 37°C in an atmosphere
containing 5% CO2. After incubation, the tissue was fixed and embedded in paraffin, and representative sections were stained with hematoxylin
and eosin. Other sections were incubated with pan-keratin Ab3 mouse monoclonal antibody (1:200), followed by anti-mouse biotinylated antibody
and HRP-conjugated high-sensitivity streptavidin for the enzymatic detection of epithelial cells (insets). (B) Representative explant from a patient
diagnosed with periodontal disease (PD). Sections were stained with hematoxylin and eosin after 24 hrs of incubation without toxin. (C) Human
gingival explants were exposed to 10 μg/mL of CdtABH160AC for 0, 18, and 36 hrs or to 10 μg/mL of CdtABC for 0 and 18 hrs. Insets show
enlarged areas designated by the red outline. (D) Dose response of HGX to the Cdt. Explants were treated with 0, 1.0, 2.5, 5.0, and 7.5 μg/mL
of CdtABC for 24 hrs. Specimens were processed and sections stained as described above. Red outlines designate areas enlarged in the next
panel. Abbreviations are the same as those described in the legend for Fig. 1. Magnification bars = 100 μm. All treatments in an experiment
were performed on pieces of tissue cut from the same explant obtained from a single patient. Experiments were performed a minimum of 3 times
on explants from different patients.

Cell nuclei, in all samples, were visualized with DAPI.
Specimens were viewed with a Nikon Eclipse 80i fluorescence
microscope. Bright-field and fluorescent digital images were
recorded with Spot Advanced 4.6 software (Diagnostic
Instruments, Inc., Sterling Heights, MI, USA).

Cell Cycle Analysis
Cell cultures were untreated (no toxin) or treated with 10 μg/mL
CdtABC or CdtABH160AC for 18-96 hrs as described previously
(Cao et al., 2005). Propidium-iodide-stained nuclei were examined on a FACSCalibur four-color dual-laser flow cytometer (BD
Biosciences, Bedford, MA, USA) at the Abramson Cancer Center
Flow Cytometry and Cell Sorting Resource Laboratory of the
University of Pennsylvania. Data from 30,000 events were analyzed with ModFit LT 3.2 (Verity Software House, NH Topsham,
ME, USA).

Results
Effects of the Cdt on Rat
Gingival Tissue
Excised rat jaw sections were incubated with increasing concentrations of CdtABC for up to 48 hrs. Untreated tissue stained with
hematoxylin-eosin typically exhibited tearing of the sulcular (SE)
and junctional (JE) epithelia (Fig. 1A). These alterations were
likely an artifact of sectioning due to soft tissue attached to the
tooth. Minor peeling of the keratinized outer layer of the OE was
also commonly observed in untreated tissue. Tissue exposed to
the 5 μg/mL CdtABC for 36 hrs had an overall swollen appearance with a pronounced thickening of the epithelial layers, extensive disruption of the keratinized layer, and distention of HGEC
in the basal layer (Fig. 1B). These effects were magnified in tissue
treated with 10 μg/mL of the toxin (Fig. 1C).
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Histidine 160 in the catalytic site of the CdtB subunit is
essential for the cell cycle arrest activity of the Cdt (Elwell
et al., 2001). Mutated subunit CdtBH160A forms a heterotrimer
with wild-type CdtA and CdtC that fails to inhibit the proliferation of susceptible cells (DiRienzo et al., 2009). Tissue exposed
to 10 μg/mL of toxin reconstituted with CdtABH160AC appeared
histologically similar to untreated tissue (Fig. 1D). These results
provided the first evidence that an explant model could be used
to study the activities of the Cdt on HGEC in situ.

Stability of Human Gingival Tissue ex vivo
In light of the findings with rat tissue, we hypothesized that the
Cdt would induce structural changes within HGX. To test this
hypothesis, it was first necessary to verify that HGX derived
from healthy gingiva could be established and maintained in
tissue culture medium for up to 24 hrs. Sections stained with
hematoxylin-eosin and labeled with a pan-keratin monoclonal
antibody contained morphologically intact OE, rete pegs (RP),
and CT (Fig. 2A). HGEC and cell junctions appeared normal.
The only evident change in the integrity of the tissue was a
slight mechanical separation of the keratinized surface layer by
18 hrs of incubation. No further deterioration of the tissue was
observed by 24 hrs. Explants derived from patients diagnosed
with periodontitis consistently displayed a highly disrupted
keratinized layer as well as distended cells and dissolution of
cell junctions in the basal cell layer of the OE (Fig. 2B).

Effects of the Cdt on Human Gingival Tissue
The histologic appearance of HGX incubated, for up to 36 hrs,
with 10 μg/mL of the mutated toxin CdtABH160AC (Fig. 2C) was
identical to that of explants incubated for 0 hr with CdtABC.
Tissue exposed to 10 μg/mL CdtABC for 18 hrs exhibited prominent histologic alterations. There was more pronounced separation of the keratinized surface layer, extensive disruption of the
epithelial layers, and marked loss of structural integrity of the RP.
The epithelial layers appeared to be swollen or thickened, and the
HGEC were dramatically distended, with an apparent loss of the
cell junctions. The morphological changes were reminiscent of
the histology of HGX from periodontitis patients (Fig. 2B).
HGX exposed to lower concentrations of the toxin (2.5 and
5.0 μg/mL) for 24 hrs exhibited detectable peeling of the keratinized outer layer and distention of spinous and basal HGEC
(Fig. 2D). Changes in the integrity of the RP and cell junctions
were not as evident in comparison with those of tissue exposed
to higher concentrations of CdtABC.

Co-localization of the Cdt and Epithelial Cells
To confirm that the Cdt targets HGEC as opposed to CT stromal
cells, we labeled sections from toxin-treated tissue with anti-CdtB
IgG. CdtB was observed primarily in the epithelial layers (red fluorescence in Fig. 3A). HGEC were localized by co-labeling with a
pan-keratin antibody (green fluorescence in Fig. 3A). Significantly
less CdtB was detected on the keratinized outer surface layer of the
gingival epithelium as well as in the underlying CT. Similar results
were obtained when the tissue was treated with CdtABH160AC

Figure 3. Localization of CdtB in human tissue treated with Cdt.
Human gingival explants were incubated with (A) 10 μg/mL of
CdtABC, (B) 10 μg/mL of CdtABH160AC, and (C) no toxin for 19 hrs.
The specimens were then co-labeled with pan-keratin Ab3 mouse
antibody (1:200) and rabbit anti-CdtB antibody (1:50,000), followed
by goat anti-mouse Alexa Fluor 488 (1:400; green fluorescence) and
goat anti-rabbit IgG Alexa Fluor 594 conjugate (1:400; red
fluorescence). Cell nuclei were visualized with DAPI (blue
fluorescence). The arrows in (A) show the location of CdtB in the
various tissue layers. The inset in (C) is a tissue section stained only
with the goat anti-mouse Alexa Fluor 488 conjugate (1:400) and
DAPI. Abbreviations are the same as in the legend for Fig. 1. GS,
gingival surface. Magnification bar = 100 μm. Experiments were
performed 3 times on explants from different patients.

(Fig. 3B). However, in this case no change in tissue morphology
was observed, as evidenced by the appearance of more well-delineated RP and non-distended HGEC. Wild-type toxin appeared to
penetrate the CT to a greater extent than CdtABH160AC. Anti-CdtB
IgG did not bind to tissue that was not exposed to the Cdt (Fig. 3C).

Effect of the Cdt on Primary Gingival
Epithelial Cells and Fibroblasts
To further support observations that the Cdt was primarily
affecting epithelial and not CT stromal cells, we isolated primary HGEC and HGF from the same type of tissue as that used
to generate HGX. Cultured primary HGEC had an epithelioid
morphology, bound Ep-CAM antibody, and failed to bind an
antibody that recognizes CD90/Thy-1 (Fig. 4A). Cultured HGF
exhibited a morphology typical of fibroblasts and bound the
CD90/Thy-1 (Ab-1) antibody. We previously showed that the
Ab-1 marker is expressed by oral fibroblasts but not by immortalized labial epithelial cells (Kang et al., 2005).
HGEC exposed to the CdtABC for 18-36 hrs were arrested
at the G2/M interphase of the cell cycle, as indicated by a
significant increase in the number of cells with a 4n DNA
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Figure 4. Effect of Cdt on cultured human primary HGEC and HGF. (A) HGEC incubated with mouse anti-human Ep-Cam (EBA-1; 1:100) antibody
and HGF labeled with anti-fibroblast CD90/Thy-1 antigen (Ab-1; 1:500) antibody. Both preparations were then labeled with Alexa Fluor 488
goat anti-mouse IgG conjugate (1:400; green fluorescence). Nuclei were stained with DAPI (blue fluorescence). The arrows show the location of
Ep-CAM on the cell surface. The inset shows cells stained only with the goat anti-mouse Alexa Fluor 488 conjugate (1:400) and DAPI. (B) Flow
cytometry of HGEC untreated and treated with 2.5 μg/mL of CdtABC for 36 hrs. The heavy black line designates the propidium iodide profile.
The inset shows HGEC treated with 10 μg/mL of CdtABH160AC for 36 hrs. Values represent percent of the total cell population in diploid G1,
diploid G2, and diploid S. (C) HGF were untreated and treated with 10 μg/mL of CdtABC for 36 hrs. The inset shows HGF exposed to CdtABC
for 96 hrs. Cell cycle experiments were performed a minimum of 3 times.

content. Cells treated for 36 hrs are shown in Fig. 4B. CdtABH160AC
had no effect on the cell cycle (inset). In contrast, there was no
increase in the number of cells having a 4n DNA content when
HGF were treated with CdtABC for 36 and 96 hrs (Fig. 4B and
inset, respectively). These results were consistent with those of
previous studies in which primary periodontal ligament fibroblasts were found to be resistant to the cell-cycle-inhibitory activity of the Cdt (Kang et al., 2005; Kanno et al., 2005).

Discussion
A. actinomycetemcomitans is a well-studied periodontal pathogen
found in periodontal lesions from individuals with disease
(Christersson et al., 1987) and has been shown to attach to (Fine et
al., 2006) and invade (Meyer et al., 1996; Lepine et al., 1998) oral
epithelial cells. This is the only oral bacterium that expresses a Cdt
(Henderson et al., 2010). Anecdotal evidence indicates that the A.
actinomycetemcomitans Cdt potentially plays a role in events associated with plaque-induced periodontal diseases. This toxin inhibits
the proliferation of oral epithelial cell lines (DiRienzo et al., 2002;
Kanno et al., 2005) and T-lymphocytes (Shenker et al., 1999) and
is expressed by non-oral pathogens associated with diseases that
involve an epithelial or mucosal layer (Ge et al., 2008). The spread
of cdt genes is most likely due to horizontal gene transfer
(Doungudomdacha et al., 2007). Thus, a major objective is to link
the biological activity of Cdt, a plausible virulence factor, directly
with the manifestations of periodontitis.

Based on the sensitivity of epithelioid cells to the Cdt
in vitro, we proposed that the effects of the toxin on oral epithelial
cells could be characterized in situ. Initially, we found that Cdtinduced tissue damage is detectable, by histological methods, in
rat gingiva. HGX were shown to survive ex vivo for up to 4 days
without evidence of degenerative changes or de-differentiation of
cells (Powell, 1967). Intense proliferative activity in the basal
HGEC was detected for up to 48 hrs (Powell, 1971). This stability
favored the use of HGX over a less authentic co-culture model
(Odioso et al., 1995). In our hands, HGX maintained their morphological integrity for up to 36 hrs ex vivo. Cdt-induced histological changes were detected by 18 hrs of incubation, well within
the window of tissue health reported previously (Powell, 1967).
Indications that tissue damage was directly related to the toxin
included distention of cells, dissolution of cell junctions, and presence of CdtB specifically in spinous and basal layers of CdtABCtreated tissue. No tissue damage was observed when tissue was
treated with toxin made with biologically inactive CdtBH160A.
Relatively more wild-type than mutated toxin was found in the
CT layer, which could be the result of increased basal epithelial
cell layer damage. Stromal cells within the CT appeared unaffected by the Cdt. This observation is consistent with the minimal
amount of CdtB detected in the CT and the failure of the toxin to
affect cell-cycle progression of cultured primary HGF. The latter
result supported earlier findings that even though the Cdt bound
to primary HPLF, the cells did not incur DNA-damage (Kang
et al., 2005; Kanno et al., 2005).
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A potential limitation of this study is that experiments with
human tissue were conducted on explants containing keratinized
OE. However, the effect of the Cdt on SE and JE can be studied
more effectively in the rat model, where intact gingiva is collected
together with adjacent alveolar bone and teeth. Pronounced Cdtinduced effects were found in the basal cell layer of HGX, suggesting that proliferating cells are extremely susceptible to the toxin.
Since the Cdt is actively secreted by the bacterium, it likely permeates the enlarged interstitial spaces of JE and into non-keratinized
forms of gingival epithelium to affect their basal cell layers.
Distention of HGEC and dissolution of cell junctions could promote more widespread penetration of the toxin throughout the tissue. Damaged epithelial cells can signal the recruitment of
inflammatory cells, increasing the extent of tissue damage due to
the production of inflammatory mediators. This extensive perturbation of the tissue allows intact bacteria access to the CT. where host
cell and bacterial products, such as lipopolysaccharide and peptidoglycan, can stimulate bone resorption.
In summary, the rat and human tissue models have potential
for studying the details of molecular interactions of the Cdt with
HGEC in situ. We clearly demonstrated that gingival tissue
exposed, ex vivo, to the toxin exhibited severe structural damage
to the epithelial layers. This localized damage supports the possibility that Cdt-induced alterations in gingival epithelial structure could play a part early in the pathogenesis of periodontitis
in the presence of A. actinomycetemcomitans. Comparison of
the histology of Cdt-treated healthy HGX and untreated explants
from several individuals with periodontal disease indicates that
morphologically similar tissue damage can occur in vivo.
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